Questions continue to come in about the big Avandia story

See new FDA information concerning the restricted use of Avandia

Questions continue to come in about the big Avandia story.

Avandia (rosiglitazone) is still in the news after an FDA panel recently recommended adding limits on its use in diabetes.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote